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Abstract
Background: Patients with multimorbidity are an increasing concern in healthcare. Clinical practice guidelines, however, do
not take into account potential therapeutic conflicts caused by co-occurring medical conditions. This makes therapeutic
decisions complex, especially in emergency situations.
Objective: The aim of this study was to identify and quantify therapeutic conflicts in emergency department patients with
multimorbidity.
Methods: We reviewed electronic records of all patients $18 years with two or more concurrent active medical conditions,
admitted from the emergency department to the hospital ward of the University Hospital Zurich in January 2009. We cross-
tabulated all active diagnoses with treatments recommended by guidelines for each diagnosis. Then, we identified potential
therapeutic conflicts and classified them as either major or minor conflicts according to their clinical significance.
Results: 166 emergency inpatients with multimorbidity were included. The mean number of active diagnoses per patient
was 6.6 (SD63.4). We identified a total of 239 therapeutic conflicts in 49% of the of the study population. In 29% of the
study population major therapeutic conflicts, in 41% of the patients minor therapeutic conflicts occurred.
Conclusions: Therapeutic conflicts are common among multimorbid patients, with one out of two experiencing minor, and
one out of three experiencing major therapeutic conflicts. Clinical practice guidelines need to address frequent therapeutic
conflicts in patients with co-morbid medical conditions.
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Introduction
Internationally comparable data with respect to the numbers of
patients with two or more concurrent medical conditions are
scarce because of heterogeneous definitions of multimorbidity.
[1,2] However, the number of patients with multimorbidity is
increasing, particularly among older adults. Almost two thirds of
all Americans older than 65 years suffer from multimorbidity. A
similar percentage (62%) has been reported from Germany. [3–5]
This makes managing the care of such patients challenging,
especially in emergency situations when physicians see the patient
for the first time and make quick decisions regarding appropriate
therapy. In such situations, evidence-based treatment guidelines
designed for single diseases can lead to serious therapeutic conflicts
and cannot be relied upon to provide guidance.
The process of systematically generating information about how
to provide appropriate medical support for specific diseases
through randomized controlled trials and then consolidating the
information in the form of generally applicable treatment
strategies known as clinical practice guidelines fails in some
notable respects. Multimorbid patients are frequently underrep-
resented or even systematically excluded from evidence-generating
studies [6–9], thus limiting the applicability of the guidelines. In
addition, potentially adverse drug-drug interactions or highly
complex or even inadequate drug regimens may pose problems.
[10–13] When the recommended therapy for treating one disease
is contraindicated in the presence of another concurrent medical
condition, this further limits the usefulness of clinical practice
guidelines. To our knowledge, there are as yet no estimates of the
burden of such therapeutic conflicts in emergency departments.
Therefore, the aim of this study was to focus on identifying and
quantifying therapeutic conflicts in cases where emergency
department patients had been diagnosed with two or more
concurrent medical conditions, and then to characterize the
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identified potential therapeutic conflicts with respect to their
clinical relevance and severity.
Methods
We designed this study as a retrospective study to estimate the
potential magnitude and scope of the problem within the context
of care provided in an emergency department.
The setting is an university teaching hospital that provides
primary, secondary, and tertiary care for a region with a
population of approximately 400,000. The hospital’s emergency
department treats about 36,000 patients annually (including
surgical patients), about 80% of whom are treated on an
outpatient basis.
All consecutive non-surgical cases entered in the emergency
department registered from January 1 through January 31, 2009,
were screened for eligibility. To be included in the study, patients
had to be 18 years of age or older and had to be admitted to a
medical ward subsequent to their admission to the emergency
department. Patients were excluded from this population if they
were not multimorbid, their cases were managed by a multidis-
ciplinary team (for example, patient care managed in the
resuscitation room) or if their medical documentation was
incomplete. Patient information was anonymized and de-identified
prior to analysis.
The study was approved by the local ethics committee
(‘‘Kantonale Ethikkommission Zu¨rich’’, www.kek.zh.ch, reference
number KEK-ZH-NR: 2010-0166/1).
Definitions
Active diagnosis was defined as a medical condition that
required diagnostic or therapeutic attention both during the time
the patient was in the emergency department and during the time
the patient was subsequently hospitalized on a medical ward.
Treatment recommendation was defined as a specific diagnostic
or therapeutic intervention that is recommended by clinical
practice guidelines for a particular diagnosis. This could include
the use of drugs (including contrast agents) or non-pharmacolog-
ical interventions (e.g., pleurocentesis or compression stockings).
Major therapeutic conflict was defined as a situation where
clinical practice guidelines recommend a treatment of one medical
condition that is absolutely contraindicated because of a co-
existing condition (for example, a situation where anticoagulation
is recommended because of a pulmonary embolism, but at the
same time contraindicated because of a co-existing gastrointestinal
bleeding).
Minor therapeutic conflict was defined as a where clinical
practice guidelines recommend a treatment of one medical
condition that is relatively contraindicated because of a co-existing
condition (for example, a situation where acetylsalicylic acid is
recommended because of a vascular disease, but at the same time
contraindicated because of a co-existing reflux esophagitis), but
where the treatment is possible without adverse effects if certain
precautions are taken.
No conflict was defined as a medical situation in which a
potential therapeutic conflict could be resolved by choosing an
equally effective alternative treatment for one of the medical
conditions, thus avoiding the conflict with respect to treatment
regimens. For example, diabetes in conjunction with severe renal
failure was not identified as posing a therapeutic conflict because
the treatment for diabetes, metformin, could be replaced with the
administration of insulin.
Data collection and analysis
Data extracted from the hospital’s electronic clinical informa-
tion system and transferred into Microsoft Excel spreadsheets
included the patient’s identification number, case number, date of
admission to the hospital, gender, age, and all active diagnoses at
the time of admission to the emergency department. Physicians’
notes, laboratory results, and medication orders available at the
time of a patient’s admission to the emergency department were
scanned for each patient. Because there is no standardized method
for identifying and classifying therapeutic conflicts, we followed a
pragmatic method of manually classifying therapeutic conflicts
through consensus by two experienced clinicians. A four-step
process was set up for investigating potential therapeutic conflicts
to ensure that definitions of medical conditions, therapies, and
treatment conflicts were applied correctly and consistently
throughout the selection and evaluation process.
Step 1: Creating a list of active diagnoses and associated
clinical practice guidelines. Two medical residents each
created a comprehensive list of the active diagnoses for each
patient. A diagnosis that was not mentioned explicitly in the initial
admission report was included if, on the basis of laboratory results,
the medical condition was obviously present. The following
diagnoses were deduced from laboratory results: anemia (hemo-
globin ,13.4 g/dL in male patients or ,11.7 g/dL in female
patients), thrombocytopenia (platelets ,143 G/L), neutropenia
(neutrophilic granulocytes ,1.40 G/L), and renal failure (estimat-
ed GFR [glomerular filtration rate] ,60 mL/min from MDRD
[Modification of Diet in Renal Disease Study Group] equation).
[14] Diagnoses were also deduced from prescriptions for
medications only if a plausible and unique indication for the
medication being prescribed was apparent. No active diagnoses
were assumed from prescriptions for medications whose use could
be prescribed for any one of several different conditions.
Each resident then classified diagnoses according to the
International Classification of Diseases (ICD-10) [15], with the
addition of codes to denote therapeutic strategies if appropriate
(for example, specifying whether diabetes type 2 was insulin
dependent or was being treated with an oral antidiabetic
medication). Quality control assurance in this step was according
to methods specified in Gilbert et al. [16]. Differences in the two
residents’ interpretations or applications of codes were discussed in
periodic meetings with senior staff physicians in order to improve
coding rules and thus improve uniformity consistency and
reproducibility in the data acquisition process.
Information about appropriate treatment recommendations for
the identified medical conditions came from relevant clinical
practice guidelines available in the evidence-based electronic
textbook UpToDate [17] without reference to any other co-
existing medical condition.
Step 2: Cross-tabulating active diagnoses and treatment
recommendations. The medical residents cross-tabulated all
active diagnoses with their corresponding evidence-based treat-
ment recommendations for each patient
Step 3: Screening for therapeutic conflicts. The medical
residents systematically and independently assessed all cases in
terms of the applicability of the treatment recommendations in
each case, taking into account all active diagnoses for co-occurring
medical conditions. Any therapeutic conflicts that they found were
characterized with respect to the type of therapy and the type of
contraindicating medical condition that was involved. Each
therapeutic regimen associated with an identified therapeutic
conflict was coded to enable counting of coincidences with the
ICD-10 codes of the conflicting co-existing medical conditions.
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Their separate assessments were compared and any differences
resolved in meetings with senior staff physicians.
Step 4: Classifying therapeutic conflicts. Senior staff
physicians classified each therapeutic conflict as either a major
or a minor conflict depending on the clinical importance and the
severity of the conflict. Differences in assessments were resolved by
consensus.
Statistical analyses
Continuous data are presented as mean and standard deviation.
Categorical data are presented as counts and proportions.
Confidence intervals for counts were based on the Poisson
distribution.
Microsoft Excel (Microsoft, WA, USA) and STATA (College
Station, TX, USA) were used for all statistical analyses.
Figure 1. Prevalence of the most frequently diagnosed medical conditions of 166 emergency patients with multimorbity*. *Only
those medical conditions diagnosed in $4% of the study population are shown PAD=peripheral artery disease; COPD= chronic obstructive
pulmonary disease.
doi:10.1371/journal.pone.0110309.g001
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Results
During the month of the study, 1520 medical patients were
treated in the emergency department of the hospital. Of these
cases, 1354 patients were excluded from the study because 1196
had been treated on an outpatient basis or were not mutlimorbid,
2 were under 18 years of age, the care of 130 had been managed
by a multidisciplinary medical team, and medical documentation
for 26 was incomplete.
Of the remaining 166 patients who were included in the study,
98 (59%) were male (Table 1). The mean age of all patients was
62.7 (SD619) years, their duration of hospitalisation was on
average 12.6 days (SD621.1).The mean number of active
diagnoses per patient was 6.6 (SD63.4) (range 2–16). About
40% of the patients had eight or more active diagnoses, and almost
14% had eleven or more active diagnoses. The most frequently
diagnosed medical conditions in these patients were hypertension
(51%), anemia (45%), and renal failure (44%). The prevalence of
the most frequently encountered medical conditions is shown in
Figure 1.
Therapeutic conflicts were identified in 82 (49.4%) of the
patients. Major therapeutic conflicts were identified in 28.9% of all
patients, minor therapeutic conflicts in 41.0% of all patients. Of
the total 239 therapeutic conflicts, 66 (27.6%) were major
therapeutic conflicts. The most frequently encountered major
conflict was between immunosuppressive therapy (mostly associ-
ated with organ transplant recipients) and a co-occurring
infectious disease. This situation existed in 10.8% of all cases.
Table 2 depicts a complete list of all identified major therapeutic
conflicts. The most frequently encountered minor therapeutic
conflict, occurring in 13.9% of all patients, was between diuretic
therapy (primarily for heart failure) and a co-occurring severe
chronic or acute renal failure or renal failure of undetermined
origin that required close renal and hemodynamic monitoring. In
table 3 a list of identified minor therapeutic conflicts is presented.
Figure 2 shows the therapies recommended by clinical practice
guidelines that were associated with therapeutic conflicts. From
the therapies indicated in more than 10% of the patients,
corticosteroids caused the highest number of therapeutic conflicts
per patient (indicated in 14% of the patients, caused 1.89
therapeutic conflicts per patient with this indication), followed by
immunosuppression (indicated in 17% of the patients, caused 1.4
therapeutic conflict per patient with this indication) and chemo-
therapy (indicated in 14% of the patients, caused 1.39 therapeutic
conflict per patient with this indication).
The number of therapeutic conflicts was significantly associated
with the number of active diagnoses per patient. On average, the
Table 1. Patient characteristics of therapeutic conflicts in 166 emergency patients with multimorbity.
Variable Number of patients Percentage of study population
Gender
Female 68 41.0%
Male 98 59.0%
Age (years)
,40 24 14.5%
40 to 59 34 20.5%
60 to 79 76 45.8%
.80 32 19.3%
Mode of admission:
Physician 62 37.3%
Self-referred 53 31.9%
Ambulance 46 27.7%
Others 5 3.0%
Number of active diagnoses per patient:
2–4 53 31.9%
5–7 46 27.7%
8–10 44 26.5%
$11 23 13.9%
Duration of hospitalization (days):
1–3 days 47 28.3%
4–7 days 39 23.5%
8–14 days 40 24.1%
$14 days 40 24.1%
Patients without therapeutic conflicts 84 50.6%
Patients with therapeutic conflicts: 82 49.4%
Patients with major conflicts only 14 8.4%
Patients with minor conflicts only 34 20.5%
Patients with both major and minor conflicts 34 20.5%
doi:10.1371/journal.pone.0110309.t001
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number of conflicts increased by 23% for every additional
diagnosis (Poisson, p,0.0005). The mean number of conflicts
per patient increased uniformly with the number of diagnoses.
Figure 3 shows the association between the number of active
diagnoses and the mean number of therapeutic conflicts per
patients.
Discussion
In this study, we identified at least one therapeutic conflict in
every second patient admitted to the emergency department and
subsequently to a hospital medical ward. Major therapeutic
conflicts were identified in every third patient. The most
commonly occurring major conflicts were in patients with an
acute infectious disease who were simultaneously undergoing
immunosuppressive therapy or chemotherapy. This constellation
of conditions and therapies accounted for almost half of the major
conflicts identified in the study. Cytopenia in patients with
immunosuppressive therapy or chemotherapy and acute bleeding
in patients who required anticoagulation or antiplatelet medica-
tion for an underlying cardiovascular disease were each found in
one fifth of all major therapeutic conflicts. The most important
source of minor therapeutic conflicts was corticosteroids because of
Table 2. Major therapeutic conflicts identified in 166 emergency patients with multimorbity*.
Type of therapy recommended by CPG Medical conflict Number of conflicts Percentage of study population
Chemotherapy 22
Infection 8 4.8%
Aplasia; neutropenia{ 4 2.4%
Thrombocytes ,50 G/L 4 2.4%
Gastroenteritis 3 1.8%
Gastrointestinal bleeding 1 0.6%
Renal failure` 1 0.6%
Hemoglobin ,6 g/dL 1 0.6%
Immunosuppression 21
Infection 18 10.8%
Aplasia; neutropenia{ 3 1.8%
Acetylsalicylic acid 9
Gastrointestinal bleeding 4 2.4%
Acetylsalicylic acid allergy 3 1.8%
Subdural hemorrhage 1 0.6%
INR .6 1 0.6%
Contrast agent 3
Renal failure` 2 1.2%
Contrast dye allergy 1 0.6%
Heparin 2
Gastrointestinal bleeding 1 0.6%
Thrombocytes ,50 G/L 1 0.6%
Antihypertensive agents 2
Orthostatic dysregulation 2 1.2%
Fluid replacement 2
Acute congestive heart failure 2 1.2%
Estrogen replacement 2
Acute coronary syndrome 2 1.2%
Oral anticoagulant 1
Gastrointestinal bleeding 1 0.6%
Pleurocentesis 1
Thrombocytes ,50 G/L 1 0.6%
Ganciclovir 1
Aplasia; neutropenia{ 1 0.6%
CPG=Clinical practice guideline.
INR = international normalized ratio index of blood coagulability.
*Major therapeutic conflict was defined as a situation where clinical practice guidelines recommend a treatment of one medical condition that is absolutely
contraindicated because of a co-existing condition.
{Neutropenia defined as neutrophilic granulocytes ,1.40 G/L.
`Renal failure defined as an estimated GFR [glomerular filtration rate] ,60 mL/min from MDRD [Modification of Diet in Renal Disease Study Group] equation.
doi:10.1371/journal.pone.0110309.t002
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Table 3. Minor therapeutic conflicts identified in 166 emergency patients with multimorbity*.
Type of therapy recommended by CPG Medical conflict Number of conflicts Percentage of study population
Steroid 53
Arterial hypertension 16 9.6%
Diabetes mellitus 13 7.8%
Osteoporosis 9 5.4%
Affective disorder 5 3.0%
Sleeping disorder 5 3.0%
Obesity 3 1.8%
Acute congestive heart failure 2 1.2%
Diuretic 28
Renal failure{ 23 13.9%
Infection 3 1.8%
Hyperparathyroidism 2 1.2%
Antihypertensive agents 26
PAD 15 9.0%
Gastrointestinal bleeding 8 4.8%
Sepsis 3 1.8%
Immunosuppression 19
Renal failure{ 15 9.0%
Gastroenteritis 2 1.2%
Carrier of multiresistant bacteria 1 0.6%
Thrombocytes ,50 G/L 1 0.6%
Beta-blocker 12
PAD 4 2.4%
Acute congestive heart failure 4 2.4%
Heart block (first-degree) 2 1.2%
Asthma 2 1.2%
Chemotherapy 10
Renal failure{ 7 4.2%
Esophagitis or GERD 2 1.2%
Skin lesion 1 0.6%
Aspirin 9
Esophagitis or GERD 8 4.8%
Peptic ulcer 1 0.6%
Opioid 5
COPD 2 1.2%
Prostate hyperplasia 2 1.2%
Constipation 1 0.6%
Compression stockings 2
PAD 2 1.2%
Fluid replacement 2
Mitral insufficiency 2 1.2%
Estrogen replacement 2
Arterial hypertension 2 1.2%
Oxygen 2
COPD 2 1.2%
Benzodiazepine 1
Encephalopathy 1 0.6%
Therapeutic Conflicts in Multimorbid Emergency Patients
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Table 3. Cont.
Type of therapy recommended by CPG Medical conflict Number of conflicts Percentage of study population
NSAID 1
Esophagitis or GERD 1 0.6%
ACE inhibitor 1
Hyperpotassemia 1 0.6%
CPG=Clinical practice guideline.
PAD=peripheral artery disease; GERD=gastroesophageal reflux disease; COPD= chronic obstructive pulmonary disease; ACE = angiotensin-converting enzyme;
NSAID = nonsteroidal anti-inflammatory drug.
*Minor therapeutic conflict was defined as a where clinical practice guidelines recommend a treatment of one medical condition that is relatively contraindicated
because of a co-existing condition, but where the treatment is possible without adverse effects if certain precautions are taken.
{Renal failure defined as an estimated GFR [glomerular filtration rate] ,60 mL/min from MDRD [Modification of Diet in Renal Disease Study Group] equation.
doi:10.1371/journal.pone.0110309.t003
Figure 2. Number of patients with recommended therapies and the associated therapeutic conflicts identified in 166 emergency
patients with multimorbity*. ACE= angiotensin-converting enzyme; NSAID=nonsteroidal anti-inflammatory drug *Major therapeutic conflict was
defined as a situation where clinical practice guidelines recommend a treatment of one medical condition that is absolutely contraindicated because
of a co-existing condition. Minor therapeutic conflict was defined as a where clinical practice guidelines recommend a treatment of one medical
condition that is relatively contraindicated because of a co-existing condition, but where the treatment is possible without adverse effects if certain
precautions are taken.
doi:10.1371/journal.pone.0110309.g002
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their potential for adversely affecting several chronic conditions
such as hypertension, diabetes, and osteoporosis.
Antihypertensive therapy was by far the most frequently
inidcated therapy (in more than 80% of the patients) overall in
the study. Mostly, it was indicated because of primary hyperten-
sion, but also in patients with cerebrovascular disease and other
vascular diseases without primary arterial hypertension mentioned
in their diagnosis list. Nevertheless, antihypertensive therapy
generated only 28 therapeutic conflicts (e.g., when indicated
in situations with co-existing gastrointestinal bleeding, sepsis, or
orthostatic dysregulation). This suggests that continuing antihy-
pertensive therapy is feasible in most situations because the broad
spectrum of antihypertensive substances available often makes it
possible to avoid conflicts by selecting an appropriate alternative
medication. Similarly, in renal failure we found that most conflicts
might be avoided by reducing the dose of the medication or by
using an alternative medication. Also, most drug allergies we
encountered rarely led to therapeutic conflicts, because equivalent
alternative therapies were available in most cases.
Previous research has used predefined lists or computer
programs to screen for potentially harmful drug-disease combina-
tions. Several lists of inappropriate or potentially harmful drug-
disease combinations have been published to date [18–22], which
several authors have used for estimating the prevalence of
potentially harmful drug-disease combinations in hospitalized
patients, a number that has ranged from 21% to 51% of the
hospitalized population. [23–28] In contrast to our study,
however, drugs and therapies that were analyzed in previous
studies were actually administered to patients. Whether these
drugs were used by mistake, by uncritically following guidelines or
whether attending physicians were taking calculated risks in these
cases remains unknown. In our study we did not measure the
incidence of potentially inappropriate prescriptions but illustrated
how potentially harmful prescriptions can emanate form clinical
practice guidelines. Thus our study also reveals a barrier to
applying clinical practice guidelines in daily clinical routine. As we
did not follow previously established criteria for potentially
inappropriate prescribing, we may have covered a broader
spectrum of potential therapy-disease interactions not covered by
predefined criteria e.g. by detecting more rarely encountered
therapeutic conflicts as well as therapeutic conflict caused by non-
pharmacological interventions such as pleurocentesis or compres-
sion stockings.
Limitations
More than 20% of the patients in our study population had an
active malignancy; more than 10% of patients were organ
transplant recipients. Many of the major therapeutic conflicts that
we identified were associated with these medical conditions. Thus,
our findings cannot be generalized to apply to hospitals that do not
provide specialized services for those medical conditions. Never-
theless, we did identify other therapeutic conflicts that are likely to
be encountered in less specialized emergency departments, such as
indications for corticosteroid therapy in patients with diabetes or
indications for anticoagulation medication in bleeding patients.
We cannot exclude the possibility that our approach to
classifying therapeutic conflicts may have biased our results to a
higher or lower rate of therapeutic conflicts. However, our finding
of therapeutic conflicts was similar to other studies that report
potential drug-disease interactions in similar settings [24,26,27].
In this pilot study, we did not investigate how therapeutic
conflicts were actually dealt with at the time of the patient’s
treatment in the emergency department and on the medical ward,
nor did we analyze whether the identified therapeutic conflicts
were relevant in terms of decisions about further clinical
management.
Conclusions
Therapeutic conflicts are common in multimorbid inpatients.
This can severely limit the applicability of clinical practice
guidelines because the recommendations for treating the respec-
tive conditions are in conflict. Although clinical guidelines cannot
address every potential therapeutic conflict, guidance should be
available for the most frequently encountered situations in which
these conflicts occur, especially for situations where the potential
for an adverse outcome is great when therapeutic issues are not
addressed.
Supporting Information
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patient (Checking applicability of treatment recommen-
dations).
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Figure 3. Mean number of therapeutic conflicts with respect to
the number of concurrent medical conditions per patient in
166 emergency patients with multimorbity. CI = confidence
interval.
doi:10.1371/journal.pone.0110309.g003
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